REFERENCES
- Substance Abuse and Mental Health Services. National Survey on Drug Use and Health. Available at: http://www.oas.samhsa.gov. Last accessed December 21, 2006.
- Hart CL, Jatlow P, Sevarino KA, Cance-Katz EF. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berl) 2000; 149:153–162.
- McCance EF, Price LH, Kosten TR, Jatlow PI. Cocaethylene: Pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 1995; 274:215–223.
- Bradberry CW, Lee T, Jatlow P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence. Psychopharmacology (Berl) 1999; 146(1):87–92.
- American Psychiatric Association (fourth ed.) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC.
- Jatlow P, Elsworth JD, Bradberry CW, Winger G, Taylor JR, Russell R, Roth RH. Cocaethylene: A neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci 1991; 48:1787–1794.
- McCance EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. Concurrent cocaine-ethanol ingestion in humans: Pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl) 1993; 111(1):39–46.
- Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin SG, Atkinson AJ, Jr. Acute tolerance to cocaine in humans. Clin Pharmacol Ther 1988; 44:1–8.